Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 81 | 2024 | 16718 | 4.120 |
Why?
|
Plaque, Atherosclerotic | 18 | 2024 | 1519 | 2.490 |
Why?
|
HIV | 16 | 2023 | 1604 | 1.600 |
Why?
|
Coronary Artery Disease | 19 | 2024 | 6487 | 1.290 |
Why?
|
Cardiovascular Diseases | 27 | 2024 | 15165 | 1.240 |
Why?
|
Monocytes | 7 | 2022 | 2596 | 0.990 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2024 | 3255 | 0.950 |
Why?
|
Atherosclerosis | 8 | 2024 | 3445 | 0.940 |
Why?
|
Anti-Retroviral Agents | 10 | 2023 | 1715 | 0.930 |
Why?
|
Heart Failure | 14 | 2023 | 10900 | 0.820 |
Why?
|
Cardiomyopathies | 4 | 2023 | 1912 | 0.800 |
Why?
|
Asymptomatic Diseases | 4 | 2018 | 551 | 0.780 |
Why?
|
Macrophage Activation | 3 | 2014 | 558 | 0.740 |
Why?
|
Arteritis | 3 | 2017 | 159 | 0.710 |
Why?
|
Heart Failure, Diastolic | 1 | 2019 | 69 | 0.660 |
Why?
|
Anti-Mullerian Hormone | 1 | 2020 | 402 | 0.620 |
Why?
|
Fibrosis | 4 | 2023 | 2029 | 0.600 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 4 | 2019 | 294 | 0.590 |
Why?
|
Myocardium | 2 | 2020 | 4776 | 0.570 |
Why?
|
Quinolines | 6 | 2024 | 732 | 0.570 |
Why?
|
Inflammation | 12 | 2024 | 10638 | 0.570 |
Why?
|
Antiretroviral Therapy, Highly Active | 6 | 2020 | 1873 | 0.560 |
Why?
|
Triglycerides | 3 | 2020 | 2454 | 0.530 |
Why?
|
Hormones | 1 | 2019 | 889 | 0.530 |
Why?
|
Sex Characteristics | 3 | 2023 | 2585 | 0.500 |
Why?
|
Stroke Volume | 6 | 2022 | 5007 | 0.490 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2022 | 2073 | 0.480 |
Why?
|
Adipose Tissue | 5 | 2023 | 3279 | 0.470 |
Why?
|
Heart | 4 | 2023 | 4467 | 0.450 |
Why?
|
Pericardium | 1 | 2018 | 667 | 0.450 |
Why?
|
Anti-HIV Agents | 7 | 2020 | 4256 | 0.440 |
Why?
|
Middle Aged | 62 | 2024 | 213383 | 0.440 |
Why?
|
Menopause | 1 | 2020 | 1626 | 0.420 |
Why?
|
Receptors, Cell Surface | 5 | 2019 | 2866 | 0.410 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.410 |
Why?
|
Aging | 2 | 2020 | 8664 | 0.390 |
Why?
|
Sex Factors | 5 | 2019 | 10397 | 0.390 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2010 | 595 | 0.380 |
Why?
|
Female | 71 | 2024 | 380194 | 0.380 |
Why?
|
Subcutaneous Fat | 4 | 2019 | 391 | 0.370 |
Why?
|
Risk Factors | 27 | 2024 | 72290 | 0.360 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 638 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2208 | 0.340 |
Why?
|
Humans | 93 | 2024 | 744343 | 0.340 |
Why?
|
Patient Selection | 2 | 2020 | 4215 | 0.320 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2559 | 0.310 |
Why?
|
Antigens, CD | 4 | 2019 | 4026 | 0.310 |
Why?
|
E-Selectin | 1 | 2010 | 579 | 0.310 |
Why?
|
Myocardial Infarction | 4 | 2023 | 11727 | 0.310 |
Why?
|
Male | 63 | 2024 | 350118 | 0.300 |
Why?
|
Patient Participation | 1 | 2017 | 1457 | 0.300 |
Why?
|
Blood Proteins | 3 | 2023 | 1124 | 0.290 |
Why?
|
Adult | 37 | 2023 | 214055 | 0.290 |
Why?
|
Cytomegalovirus Infections | 2 | 2024 | 820 | 0.290 |
Why?
|
Cholesterol | 2 | 2018 | 2917 | 0.280 |
Why?
|
Aorta | 3 | 2020 | 2061 | 0.250 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3610 | 0.250 |
Why?
|
Coronary Angiography | 9 | 2024 | 4577 | 0.250 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4560 | 0.250 |
Why?
|
Lipids | 2 | 2014 | 3305 | 0.250 |
Why?
|
Health Promotion | 1 | 2017 | 2205 | 0.250 |
Why?
|
Obesity | 5 | 2018 | 12745 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2022 | 4420 | 0.230 |
Why?
|
Macrophages | 2 | 2022 | 5655 | 0.230 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2012 | 2232 | 0.230 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.220 |
Why?
|
Lipoproteins, LDL | 2 | 2024 | 640 | 0.220 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2023 | 127 | 0.210 |
Why?
|
Nucleosides | 1 | 2022 | 138 | 0.210 |
Why?
|
HIV Integrase | 1 | 2023 | 120 | 0.210 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5524 | 0.200 |
Why?
|
HIV Integrase Inhibitors | 1 | 2023 | 142 | 0.200 |
Why?
|
Proteomics | 5 | 2023 | 3638 | 0.200 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 25043 | 0.190 |
Why?
|
Insulin Resistance | 3 | 2018 | 3864 | 0.190 |
Why?
|
Death, Sudden, Cardiac | 2 | 2019 | 1541 | 0.190 |
Why?
|
Proteinuria | 1 | 2023 | 658 | 0.180 |
Why?
|
Multicenter Studies as Topic | 3 | 2020 | 1677 | 0.180 |
Why?
|
Ventricular Function, Left | 3 | 2022 | 3670 | 0.180 |
Why?
|
Case-Control Studies | 8 | 2022 | 21746 | 0.180 |
Why?
|
Integrases | 1 | 2022 | 533 | 0.180 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2020 | 3760 | 0.170 |
Why?
|
Coronary Disease | 1 | 2014 | 6077 | 0.170 |
Why?
|
Inflammation Mediators | 2 | 2022 | 1889 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11725 | 0.170 |
Why?
|
Proteome | 2 | 2020 | 1799 | 0.170 |
Why?
|
Viral Load | 5 | 2022 | 3299 | 0.170 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2022 | 615 | 0.170 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2023 | 570 | 0.170 |
Why?
|
Stroke | 3 | 2018 | 9981 | 0.170 |
Why?
|
Body Composition | 5 | 2018 | 2401 | 0.170 |
Why?
|
North America | 2 | 2024 | 1249 | 0.160 |
Why?
|
Caspase 1 | 1 | 2019 | 224 | 0.160 |
Why?
|
Coronary Vessels | 4 | 2023 | 3107 | 0.160 |
Why?
|
HIV Long-Term Survivors | 1 | 2019 | 126 | 0.160 |
Why?
|
Research Subjects | 1 | 2020 | 239 | 0.160 |
Why?
|
Simian immunodeficiency virus | 1 | 2023 | 846 | 0.150 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2017 | 68 | 0.150 |
Why?
|
Mannans | 1 | 2017 | 63 | 0.150 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 100 | 0.140 |
Why?
|
Uganda | 4 | 2022 | 1243 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 300 | 0.140 |
Why?
|
Prospective Studies | 11 | 2022 | 53288 | 0.140 |
Why?
|
Anticholesteremic Agents | 3 | 2018 | 979 | 0.140 |
Why?
|
Aged | 18 | 2023 | 163280 | 0.140 |
Why?
|
Reproduction | 1 | 2020 | 668 | 0.130 |
Why?
|
Young Adult | 8 | 2020 | 56430 | 0.130 |
Why?
|
Dextrans | 1 | 2017 | 595 | 0.130 |
Why?
|
Pravastatin | 1 | 2017 | 395 | 0.130 |
Why?
|
Comorbidity | 3 | 2018 | 10388 | 0.130 |
Why?
|
Gender Identity | 1 | 2020 | 688 | 0.120 |
Why?
|
Protease Inhibitors | 1 | 2018 | 791 | 0.120 |
Why?
|
Cholesterol, HDL | 2 | 2018 | 1814 | 0.120 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.120 |
Why?
|
Apolipoproteins C | 2 | 2004 | 59 | 0.120 |
Why?
|
HIV-1 | 2 | 2023 | 6939 | 0.120 |
Why?
|
Amino Acids | 1 | 2020 | 1736 | 0.120 |
Why?
|
Lectins, C-Type | 1 | 2017 | 588 | 0.120 |
Why?
|
United States | 8 | 2023 | 69872 | 0.120 |
Why?
|
Intra-Abdominal Fat | 1 | 2019 | 591 | 0.120 |
Why?
|
Angiography | 2 | 2016 | 1639 | 0.110 |
Why?
|
Patient Readmission | 4 | 2023 | 3114 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 9959 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2017 | 952 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 35421 | 0.110 |
Why?
|
Incidence | 7 | 2019 | 20947 | 0.110 |
Why?
|
Apolipoprotein A-I | 2 | 2004 | 281 | 0.110 |
Why?
|
Adolescent | 7 | 2018 | 85781 | 0.100 |
Why?
|
Double-Blind Method | 6 | 2024 | 12026 | 0.100 |
Why?
|
Community Health Services | 1 | 2017 | 650 | 0.100 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 280 | 0.100 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2012 | 138 | 0.100 |
Why?
|
Osteopontin | 2 | 2023 | 296 | 0.100 |
Why?
|
Risk Assessment | 5 | 2022 | 23338 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 2872 | 0.100 |
Why?
|
Immunophenotyping | 1 | 2016 | 1880 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 882 | 0.100 |
Why?
|
Body Mass Index | 4 | 2023 | 12720 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2018 | 832 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 5 | 2019 | 20129 | 0.100 |
Why?
|
Europe | 1 | 2017 | 3339 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1782 | 0.090 |
Why?
|
Regression Analysis | 2 | 2018 | 6459 | 0.090 |
Why?
|
Sulfotransferases | 1 | 2011 | 151 | 0.090 |
Why?
|
Prevalence | 4 | 2022 | 15226 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2050 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 175 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 944 | 0.090 |
Why?
|
American Heart Association | 1 | 2014 | 1056 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1889 | 0.080 |
Why?
|
Cytomegalovirus | 2 | 2024 | 732 | 0.080 |
Why?
|
Primary Prevention | 3 | 2023 | 1167 | 0.080 |
Why?
|
Receptors, Chemokine | 2 | 2022 | 669 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3200 | 0.080 |
Why?
|
Adipokines | 1 | 2010 | 319 | 0.080 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2187 | 0.080 |
Why?
|
Antibodies, Viral | 3 | 2024 | 3176 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2017 | 1580 | 0.080 |
Why?
|
Extremities | 1 | 2012 | 865 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2645 | 0.070 |
Why?
|
Cholesterol, LDL | 3 | 2024 | 2356 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2012 | 2016 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2278 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3778 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2017 | 3474 | 0.070 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2019 | 841 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8554 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Response Elements | 1 | 2004 | 312 | 0.050 |
Why?
|
Positron-Emission Tomography | 3 | 2014 | 6234 | 0.050 |
Why?
|
Macaca | 1 | 2023 | 440 | 0.050 |
Why?
|
Body Weight | 1 | 2012 | 4669 | 0.050 |
Why?
|
Contrast Media | 1 | 2014 | 5300 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7913 | 0.050 |
Why?
|
CD4-CD8 Ratio | 1 | 2020 | 112 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2021 | 434 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18370 | 0.040 |
Why?
|
Vital Capacity | 1 | 2022 | 925 | 0.040 |
Why?
|
Muscles | 1 | 2024 | 1614 | 0.040 |
Why?
|
Blood Glucose | 3 | 2021 | 6256 | 0.040 |
Why?
|
Drug Resistance, Viral | 1 | 2023 | 820 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2021 | 582 | 0.040 |
Why?
|
Cause of Death | 2 | 2019 | 3584 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4386 | 0.040 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2017 | 39 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 249 | 0.040 |
Why?
|
Glucose Tolerance Test | 2 | 2011 | 1150 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2022 | 1743 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2004 | 1341 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7279 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15076 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 440 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 354 | 0.040 |
Why?
|
Transsexualism | 1 | 2020 | 178 | 0.040 |
Why?
|
Tomography, X-Ray | 1 | 2016 | 61 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2021 | 77449 | 0.030 |
Why?
|
Muscle Cells | 1 | 2016 | 197 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 537 | 0.030 |
Why?
|
Cocaine-Related Disorders | 1 | 2019 | 460 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13989 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9734 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2019 | 1438 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1676 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12354 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3701 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2118 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2004 | 3036 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4161 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5867 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.030 |
Why?
|
Apolipoprotein C-III | 2 | 2004 | 202 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12245 | 0.030 |
Why?
|
Mice | 5 | 2023 | 81183 | 0.030 |
Why?
|
Self Report | 1 | 2022 | 3558 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3508 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2021 | 5974 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2012 | 223 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17446 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2018 | 63114 | 0.020 |
Why?
|
Hospitalization | 2 | 2019 | 10262 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1440 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 21683 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3749 | 0.020 |
Why?
|
Liver | 1 | 2004 | 7474 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4931 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1938 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2210 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5097 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4034 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2864 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.020 |
Why?
|
Animals | 5 | 2023 | 168757 | 0.020 |
Why?
|
Time Factors | 2 | 2018 | 40075 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 2958 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9648 | 0.020 |
Why?
|
Adiponectin | 1 | 2011 | 1100 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9313 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 12072 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5987 | 0.020 |
Why?
|
Diet | 1 | 2022 | 7939 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2400 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5952 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2017 | 3265 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1599 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2003 | 118 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
Base Sequence | 2 | 2004 | 12797 | 0.010 |
Why?
|
Genes, Regulator | 1 | 2003 | 378 | 0.010 |
Why?
|
Mutation | 2 | 2004 | 29786 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2003 | 1085 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8089 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19229 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2003 | 315 | 0.010 |
Why?
|
Multigene Family | 1 | 2004 | 1102 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2282 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18029 | 0.010 |
Why?
|
Pharmacogenetics | 1 | 2003 | 675 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1783 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39050 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 6114 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2003 | 2440 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7722 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 18111 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15997 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 21827 | 0.000 |
Why?
|
Transcription Factors | 1 | 2003 | 12208 | 0.000 |
Why?
|